AbbVie Inc. (ABBV)

72.86
3.30 4.40
NYSE : Health Technology
Prev Close 76.19
Open 72.12
Day Low/High 71.43 / 73.99
52 Wk Low/High 62.55 / 97.86
Volume 5.06M
Avg Volume 11.80M
Exchange NYSE
Shares Outstanding 1.48B
Market Cap 107.31B
EPS 5.30
P/E Ratio 40.24
Div & Yield 4.72 (6.04%)

Latest News

Jim Cramer: Panicking Never Made Anyone a Dime, but These Will

Jim Cramer: Panicking Never Made Anyone a Dime, but These Will

Here are six companies that should come through in the tough times ahead.

Jim Cramer: Let's See Who's Safe, Who Isn't

Jim Cramer: Let's See Who's Safe, Who Isn't

You can use these wild market swings to your advantage by identifying 'safe' companies you want to own and then buying their stocks in stages.

Jim Cramer: Rate Cut No Cure for Coronavirus

Jim Cramer: Rate Cut No Cure for Coronavirus

But don't throw up your arms yet -- here are names that could be golden opportunities.

Jim Cramer: I Don't Know Where It Will Bottom, I Do Know What to Buy and Sell

Jim Cramer: I Don't Know Where It Will Bottom, I Do Know What to Buy and Sell

This is the time to high grade your portfolio, take some losses and move to better stocks.

AbbVie Could Be One of the Stocks That Recovers Before Others

AbbVie Could Be One of the Stocks That Recovers Before Others

Let's review the charts and indicators.

Three Strategies for Income Investors

Three Strategies for Income Investors

For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.

Coronavirus Spreads, Reducing 'Big Oil', 4 Stocks to Watch, Adding Store Capital

Coronavirus Spreads, Reducing 'Big Oil', 4 Stocks to Watch, Adding Store Capital

Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.

Tech Based Rally, Real-Life Virus, Powell Speaks, Tracking 5 Stocks

Tech Based Rally, Real-Life Virus, Powell Speaks, Tracking 5 Stocks

This rally has been industry, not sector led, and it is all based on technology, whether or not market leaders reside within the Tech sector or not.

Watch These Biotech Names on Strong Earnings

Watch These Biotech Names on Strong Earnings

Merger activity is the number 1 driver I am watching for biotech growth.

Coronavirus at Sea, Mahalanobis Distance, Trading 3 Stocks: Market Recon

Coronavirus at Sea, Mahalanobis Distance, Trading 3 Stocks: Market Recon

I'm watching the shares of Estee Lauder, Disney and Amazon.

Decisions, Decisions: AbbVie or Bristol-Myers Squibb?

Decisions, Decisions: AbbVie or Bristol-Myers Squibb?

AbbVie's weekly chart indicates its stock has room to run long term, but its daily chart suggests a rally in its shares is not imminent.

Jim Cramer: Panic Has Not Been Contained in This Market

Jim Cramer: Panic Has Not Been Contained in This Market

I think, ultimately, the big issue for many will be what happens in the United States if we hear about people who didn't go to China who have come down with the disease.

Why AbbVie Looks Like a Bargain at These Levels

Why AbbVie Looks Like a Bargain at These Levels

Nobody in AbbVie right now is in it for the past performance.

A Technical Strategy for AbbVie as the Broader Market Gets Rocked

A Technical Strategy for AbbVie as the Broader Market Gets Rocked

ABBV could bounce today but there remains the risk of a deeper correction.

Coronavirus Is Now a Market Story, Watching the U.S. 10 Year Note, Kobe Bryant

Coronavirus Is Now a Market Story, Watching the U.S. 10 Year Note, Kobe Bryant

Chinese President Xi Jinping, not a man given to exaggerate, has referred to the spread of this coronavirus in China as 'a grave situation.'

Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

Jim Cramer: 6 Stocks to Buy on Coronavirus Fears

These companies all could be strong -- even if the 2019 nCoV fear spreads.

4 Favorite Biotech Stock Picks for 2020

4 Favorite Biotech Stock Picks for 2020

The Medical Technology Stock Letter's top pick rose 357% in 2019.

Jim Cramer: Don't Get Sacked in This Political Football Match

Jim Cramer: Don't Get Sacked in This Political Football Match

How to prepare your portfolio and be opportunistic in the face of this geopolitical instability.

This Dividend Aristocrat Is Our Top Pick for 2020

This Dividend Aristocrat Is Our Top Pick for 2020

As it smooths out the wrinkles from 2019, this pharmaceutical manufacturer should have a healthy year.

My Pick for 2020? You Won't Believe It's Been on Your Screen All Along

My Pick for 2020? You Won't Believe It's Been on Your Screen All Along

This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.

Individual Investors Are Back! Trading Cisco: Market Recon

Individual Investors Are Back! Trading Cisco: Market Recon

It seemed to happen overnight. People watched. People listened. People cared. About what? Individual stocks.

Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not

Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not

We're seeing lots of companies snapping up their peers, and the market is applauding.

Cash Stashes Dwindle as Markets Crest and Powell Speaks: Market Recon

Cash Stashes Dwindle as Markets Crest and Powell Speaks: Market Recon

Plus, we preview Wednesday's Trump-Erdogan meeting and check out AbbVie's huge debt offering as well as the new Abode-Microsoft connection.

Jim Cramer: Here's the Good News About the U.S./China Trade Delay

Jim Cramer: Here's the Good News About the U.S./China Trade Delay

There are plenty of stocks that have been thrown away for several weeks because of a belief that the Fed and a trade deal will avoid a recession.

Drug Companies Are a Political Football, Trading Amgen: Market Recon

Drug Companies Are a Political Football, Trading Amgen: Market Recon

The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.

Jim Cramer: Drug Stocks Are Too Cheap

Jim Cramer: Drug Stocks Are Too Cheap

These stocks are priced for total imperfection. That's just what you want.